Is there a need for viral load testing to assess treatment failure in HIV-infected patients who are about to change to tenofovir-based first-line antiretroviral therapy? Programmatic findings from Myanmar
Aimed to determine prevalence and determinants of ART failure in those on first-line treatment
Thiha, N, Chinnakali, P, Harries, A.D., Shwe, M, Balathandan, T.P., Tun, S.T.T., et all
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced with tenofovir (TDF) for first-line treatment.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Thiha N, Chinnakali P, Harries AD, Shwe M, Balathandan TP, Thein Than Tun S, et al. (2016) Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar. PLoS ONE 11(8): e0160616. doi:10.1371/journal.pone.0160616